Showing results (61-70 of 150) with videos related to
Sort By:
Pageof 15
Current Oncology (Toronto, Ont.)|June 2, 2021
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro, et al.Frontiers in Oncology|June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast CancerEva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.World Journal of Gastroenterology|February 28, 2014
Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenibAndrea L Inghilesi, Donatella Gallori, Lorenzo Antonuzzo, et al.Lung Cancer (Amsterdam, Netherlands)|May 29, 2009
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markersMarcello Tiseo, Giulio Rossi, Marzia Capelletti, et al.Trials|March 19, 2013
Sustained lung inflation in the delivery room in preterm infants at high risk of respiratory distress syndrome (SLI STUDY): study protocol for a randomized controlled trialCarlo Dani, Gianluca Lista, Simone Pratesi, et al.British Journal of Cancer|April 30, 2020
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Marcello Tiseo, Fausto Barbieri, et al.The British Journal of Surgery|July 20, 2023
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, et al.JAMA|January 1, 2016
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical TrialMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.Journal of the National Cancer Institute|December 1, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer PatientsMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.JAMA|July 21, 2011
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trialLucia Del Mastro, Luca Boni, Andrea Michelotti, et al.Pageof 15